Results 211 to 220 of about 98,807 (272)

Deciphering RTK-RAS and MAPK Pathway Dependencies in Gemcitabine-Treated Pancreatic Ductal Adenocarcinoma Through Conversational Artificial Intelligence. [PDF]

Int J Mol Sci
Diaz FC, Waldrup B, Carranza FG, Manjarrez S, Velazquez-Villarreal E.   +4 more
europepmc   +1 more source

The bile acid TUDCA promotes chemoresistance and predicts survival through MAPK signaling in pancreatic ductal adenocarcinoma. [PDF]

Cell Mol Life Sci
Wang Y, Xue S, Xu H, Ma J, Wu S, Guo K, Fang Y, Cui J, Wang L.   +8 more
europepmc   +1 more source

Trans-arterial gemcitabine micro perfusion of locally advanced pancreatic cancer enabled by coil plus glue embolization of a pancreaticoduodenal branch. [PDF]

Radiol Case Rep
Kis B, Bishop O, Salloum E, Al-Roubaie M, Kim DW, Agah R.   +5 more
europepmc   +1 more source

Durable response to chemoimmunotherapy in a patient with refractory metastatic ovarian clear cell carcinoma: a case report and literature review. [PDF]

Oncologist
Wang L, Chen X, Li Y, Chang H, Meng X.
europepmc   +1 more source

Single-Institution Outcomes of Neoadjuvant Gemcitabine and Nab-Paclitaxel Combination in Borderline Resectable Pancreatic Adenocarcinoma: A Three-Year Retrospective Audit. [PDF]

Cureus
Ramidi GR, Yadav R, Patnaik A, Sunny G.
europepmc   +1 more source

Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future. [PDF]

Hepatobiliary Surg Nutr
Hernandez S, Maker AV.
europepmc   +1 more source

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era. [PDF]

Front Surg
Bartsch F, Scholz C, Gröger LK, Bachmann L, Baumgart J, Lederer AK, Mittler J, Hoppe-Lotichius M, Straub BK, Foerster F, Weinmann A, Tagkalos E, Lang H.   +12 more
europepmc   +1 more source

Use of Phosphorus-32 Microparticles for Downstaging Locally Advanced Pancreatic Cancer to Resection: A Case Report. [PDF]

Cureus
Pereira F, Juez I, Peiro V, Guardiola A, Del Riego C, Haro P.   +5 more
europepmc   +1 more source

Chemotherapy-induced activation of caspase-1 and IL-1α release by cancer cells remotely skews myelopoiesis to drive pro tumorigenic systemic neutrophil-dominant inflammation. [PDF]

Nat Commun
Wong SQ, Hayashi K, Subel EJ, Huang YH, Gao H, Garcia HE, Porter SJ, Karabicici M, Hoi XP, Alonzo MD, Kasabyan A, Tsouko E, Shin CS, Bouchier-Hayes L, Korentzelos D, Chen C, Brooks M, Yin Z, Titus RS, Zhou L, Gong Y, Li Y, Wong ST, El-Zaatari Z, Kaushik D, Satkunasivam R, Nikolos F, Chan KS.   +27 more
europepmc   +1 more source

Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC). [PDF]

Oncoimmunology
Sanborn RE, Jensen SM, Paustian C, Chang SC, Vetto E, Vu Q, Rajamanickam V, Bernard B, Koguchi Y, Redmond WL, Fox BA.   +10 more
europepmc   +1 more source